West Pharmaceutical Services, Inc. Share Price Sao Paulo

Equities

W2ST34

BRW2STBDR007

Medical Equipment, Supplies & Distribution

Market Closed - Sao Paulo 14:00:05 27/06/2024 BST 5-day change 1st Jan Change
50.35 BRL +0.30% Intraday chart for West Pharmaceutical Services, Inc. +3.60% +2.65%

Financials

Sales 2024 * 3.01B 16.85B 238B Sales 2025 * 3.28B 18.34B 259B Capitalization 23.99B 134B 1,898B
Net income 2024 * 570M 3.19B 45.08B Net income 2025 * 668M 3.74B 52.84B EV / Sales 2024 * 7.76 x
Net cash position 2024 * 617M 3.45B 48.78B Net cash position 2025 * 1.02B 5.68B 80.29B EV / Sales 2025 * 7.01 x
P/E ratio 2024 *
42.7 x
P/E ratio 2025 *
37.2 x
Employees 10,600
Yield 2024 *
0.28%
Yield 2025 *
0.33%
Free-Float 96.38%
More Fundamentals * Assessed data
Dynamic Chart
West Pharmaceutical Services Insider Sold Shares Worth $595,404, According to a Recent SEC Filing MT
Transcript : West Pharmaceutical Services, Inc. Presents at The 44th Annual William Blair Growth Stock Conference, Jun-04-2024 08:00 AM
West Pharmaceutical Services, Inc. Introduces Daikyo Crystal Zenith® Ready-to-Use Nested Vials in Tub at the International Society for Cell and Gene Therapy CI
Transcript : West Pharmaceutical Services, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 11:20 AM
West Pharmaceutical Services Insider Sold Shares Worth $24,199,050, According to a Recent SEC Filing MT
Declaration of Voting Results of the West Pharmaceutical Services Inc CI
Bernard Birkett No Longer Have Principal Operating Officer Position of West Pharmaceutical Services, Inc CI
UBS Adjusts West Pharmaceutical Services Price Target to $390 From $375, Maintains Neutral Rating MT
Jefferies Adjusts Price Target on West Pharmaceutical Services to $426 From $423 MT
Health Care Drops Amid Mixed Earnings -- Health Care Roundup DJ
Tranche Update on West Pharmaceutical Services, Inc.'s Equity Buyback Plan announced on February 16, 2023. CI
Transcript : West Pharmaceutical Services, Inc., Q1 2024 Earnings Call, Apr 25, 2024
Stephens Adjusts West Pharmaceutical Services Price Target to $420 From $400 MT
Earnings Flash (WST) WEST PHARMACEUTICAL SERVICES Reports Q1 Revenue $695.4M, vs. Street Est of $671.7M MT
Earnings Flash (WST) WEST PHARMACEUTICAL SERVICES Posts Q1 EPS $1.56, vs. Street Est of $1.29 MT
More news
1 day+0.30%
1 week+3.60%
Current month+4.46%
1 month+3.49%
3 months-8.12%
6 months+2.65%
Current year+2.65%
More quotes
1 week
50.20
Extreme 50.2
51.90
1 month
48.60
Extreme 48.6
51.90
Current year
48.05
Extreme 48.05
57.72
1 year
48.05
Extreme 48.05
57.72
3 years
30.70
Extreme 30.7
75.51
5 years
30.70
Extreme 30.7
75.51
10 years
30.70
Extreme 30.7
75.51
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 23/04/15
Director of Finance/CFO 55 20/06/18
Chief Tech/Sci/R&D Officer 52 25/02/18
Members of the board TitleAgeSince
Director/Board Member 66 31/01/11
Chief Executive Officer 55 23/04/15
Director/Board Member 63 11/09/16
More insiders
Date Price Change Volume
27/06/24 50.35 +0.30% 10
25/06/24 50.2 -3.28% 10

Delayed Quote Sao Paulo, June 27, 2024 at 02:00 pm

More quotes
West Pharmaceutical Services, Inc. specializes in the design, manufacture and marketing of components and systems for the containment and delivery of injectable drugs. The group offers packaging, components for syringes, cartridge systems, auto-injection devices, accessories for vials, specialty components, etc. Net sales break down by family of products as follows: - own manufactured products (81.8%); - products manufactured under contract (18.2%). Net sales are distributed geographically as follows: the United States (42.3%), Germany (16.8%), Ireland (8.7%), France (7.5%), Europe (12.1%) and other (12.6%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
329.4 USD
Average target price
397.5 USD
Spread / Average Target
+20.68%
Consensus